-- dump date   	20140618_203224
-- class       	Genbank::Contig
-- table       	contig_comment
-- id	comment
NC_021252.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to CP003410.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to CP003410. Bacteria available from Shanghai Laiyi Center forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to CP003410. Bacteria available from Shanghai Laiyi Center for Biopharmaceuticals R&D, Shanghai 201203, P.R. China,PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to CP003410. Bacteria available from Shanghai Laiyi Center for Biopharmaceuticals R&D, Shanghai 201203, P.R. China, hccbred@gmail.com.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to CP003410. Bacteria available from Shanghai Laiyi Center for Biopharmaceuticals R&D, Shanghai 201203, P.R. China, hccbred@gmail.com. ##Assembly-Data-START##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to CP003410. Bacteria available from Shanghai Laiyi Center for Biopharmaceuticals R&D, Shanghai 201203, P.R. China, hccbred@gmail.com. ##Assembly-Data-START## Assembly Method       :: Newbler v. v2.5PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to CP003410. Bacteria available from Shanghai Laiyi Center for Biopharmaceuticals R&D, Shanghai 201203, P.R. China, hccbred@gmail.com. ##Assembly-Data-START## Assembly Method       :: Newbler v. v2.5 Sequencing Technology :: Sanger dideoxy sequencing; 454; IlluminaPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to CP003410. Bacteria available from Shanghai Laiyi Center for Biopharmaceuticals R&D, Shanghai 201203, P.R. China, hccbred@gmail.com. ##Assembly-Data-START## Assembly Method       :: Newbler v. v2.5 Sequencing Technology :: Sanger dideoxy sequencing; 454; Illumina ##Assembly-Data-END##PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to CP003410. Bacteria available from Shanghai Laiyi Center for Biopharmaceuticals R&D, Shanghai 201203, P.R. China, hccbred@gmail.com. ##Assembly-Data-START## Assembly Method       :: Newbler v. v2.5 Sequencing Technology :: Sanger dideoxy sequencing; 454; Illumina ##Assembly-Data-END## COMPLETENESS: full length.
NC_023497.1	PROVISIONAL REFSEQ: This record has not yet been subject to finalPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to CP003411.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to CP003411. Bacteria available from Shanghai Laiyi Center forPROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to CP003411. Bacteria available from Shanghai Laiyi Center for Biopharmaceuticals R&D, Shanghai 201203, P.R. China,PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to CP003411. Bacteria available from Shanghai Laiyi Center for Biopharmaceuticals R&D, Shanghai 201203, P.R. China, hccbred@gmail.com.PROVISIONAL REFSEQ: This record has not yet been subject to final NCBI review. The reference sequence is identical to CP003411. Bacteria available from Shanghai Laiyi Center for Biopharmaceuticals R&D, Shanghai 201203, P.R. China, hccbred@gmail.com. COMPLETENESS: full length.